Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

Whole-body screening MRI (wb-MRI) for asymptomatic patients has become a relevant topic for U.S. cancer centers. There is a growing number of for-profit centers offering wb-MRI scans for asymptomatic ...

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

The result is Ezra (Hebrew for “help”), the full-body MRI scanning company Gal founded in 2018. In 2025, it was acquired by ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

Abbreviated biparametric MRI was noninferior to full multiparametric MRI in detecting clinically significant prostate cancer in the prospective PRIME study, suggesting that it could become the new ...

Function Health is a platform that provides patients with access to over 160 lab tests at a single cost of $499 per year. These tests helps people at every life stage understand their current health, ...

A full-body scan every few years, for some, is a small price to pay for a wide-ranging check-up. Is it the right choice for ...

VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual tumor marker designed to provide artifact-free visibility across all major breast imaging ...

Calvin Sun was a healthy 37-year-old when a full-body MRI scan showed a cyst in his kidney. Sun saw a urologist who was cautiously optimistic that it wasn’t cancerous and offered him a surgery ...

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...